The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA moves toward easing restrictions on certain peptides BioPharma Dive Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.